Company
Every investor coverage indicates participated in a round Yale University raised.
Companies Yale University acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Prof Anna Marie Pyle | Sterling Professor | Brandon Capital portfolio, Brandon BioCatalyst portfolio |
Stories naming Yale University. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Rokt hires former Google and Amazon engineering executive Claire Southey for its Sydney engineering leadership, with other senior hires, as the ecommerce marketing firm eyes a future public listing.
Also Startup Daily
Cancer biotech Amaroq Therapeutics appointed four experts to its advisory board as it moves toward clinical trials; the New Zealand company's backers include Brandon Capital, which reports $14m invested to date.
New Zealand biotech Amaroq Therapeutics reported early progress toward clinical trials and appointed four leading scientists to its scientific advisory board, strengthening its lncRNA cancer therapy programme.
Blackbird's investment note announcing it led Forage's US$25 million Series B alongside Lightspeed, Funders Club and new backers, with Tom Humphrey joining the board, plus a profile of Forage's preskilling platform.
Also Startup Daily·Startup Daily·Startup Daily·Forbes Australia
Preserve Health, the Flinders University spin-out behind PREPD hydration drinks, raised over A$950,000 in a pre-Series A round from shareholders and private investors including cycling coach Kevin Poulton, funding national growth and a US launch.
A 2005 notice that Portland Orthopaedics, a Sydney hip and knee implant maker, planned a $5 million IPO, with a December ASX listing expected and Axis Financial Group brokering the offer.